Famotidine NDC 81033-023

NDC codes

FDA NDC Directory

Product NDC (as listed)81033-023Labeler and product segments. Claims need a package NDC.

Product NDC at billing width81033-0023Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
81033-023-50	81033002350	50 mL in 1 BOTTLE (81033-023-50)Marketed from Nov 25, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Famotidine
Generic name (nonproprietary): famotidine
Active ingredients: Famotidine — 40 mg/5mL
Dosage form: Powder, For suspension
Route: Oral
Labeler: Kesin Pharma Corporation
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217137
Marketing start: Aug 10, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 81033-023_446ca547-846c-dd5b-e063-6394a90a1baeSPL ID 446ca547-846c-dd5b-e063-6394a90a1bae
Pharmacologic class: Histamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N481033002350 followed by a unit qualifier and the quantity

Package 81033-0023-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 217137

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217137
Product	Strength	Form · route	Labeler	Product NDC
Famotidine	Famotidine 40 mg/5mL	Powder, For suspensionOral	Biocon Pharma Inc.	70377-113
Famotidine	Famotidine 40 mg/5mL	Powder, For suspensionOral	Bryant Ranch Prepack	72162-2599
Famotidine	Famotidine 40 mg/5mL	Powder, For suspensionOral	Carnegie Pharmaceuticals LLC	80005-119